Common polymorphisms in the CTLA-4 and CD28 genes at 2q33 are not associated with asthma or atopy

Eur J Immunogenet. 2000 Apr;27(2):57-61. doi: 10.1046/j.1365-2370.2000.00198.x.

Abstract

Recently, genetic linkage of the chromosomal region 2q33 with asthma has been shown. The genes coding for CD28 and CTLA-4 have been localized to this chromosomal region. CD28 and CTLA-4 have been shown to be involved as an important costimulatory signal in the regulation of allergic inflammation and TH2 cytokine production, and thus both genes are good candidate genes for asthma and atopy. Two common polymorphisms in the CTLA-4 gene and one polymorphism in the CD28 gene found by single-strand conformation polymorphisms (SSCP) analysis and direct genomic sequencing were tested for association with asthma and atopy phenotypes in a population of 260 largely atopic children and young adults. No association was found between any of the three polymorphisms and asthma or atopy phenotypes. The newly described common CD28 polymorphism is situated in the third intron of the gene. We conclude that neither gene is likely to exert a major influence on the development of asthma or atopy in our population. However, it might prove useful to test for association of these polymorphisms with asthma in populations recruited through asthmatic but not necessarily atopic individuals.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Abatacept
  • Adolescent
  • Adult
  • Alleles
  • Antigens, CD
  • Antigens, Differentiation / genetics*
  • Asthma / genetics*
  • CD28 Antigens / genetics*
  • CTLA-4 Antigen
  • Child
  • Chromosomes, Human, Pair 2*
  • Female
  • Genetic Markers
  • Humans
  • Hypersensitivity, Immediate / genetics*
  • Immunoconjugates*
  • Male
  • Polymorphism, Genetic*

Substances

  • Antigens, CD
  • Antigens, Differentiation
  • CD28 Antigens
  • CTLA-4 Antigen
  • CTLA4 protein, human
  • Genetic Markers
  • Immunoconjugates
  • Abatacept